Anti-Human HLA-DR PE-Cyanine5

Clone: LN3

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 15-9956

Cat. No. Size
15-9956-41 25 tests
15-9956-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human HLA-DR PE-Cy5.

Staining of normal human peripheral blood cells with Mouse IgG2b Isotype Control PE-Cyanine5 (cat....View More

  • Data for Anti-Human HLA-DR PE-Cy5.
Description

Description: The LN3 mAb reacts with the human major histocompatibility complex (MHC) class II, HLA-DR. HLA-DR is expressed on the surface of human antigen presenting cells (APC) including B cells, monocytes, macrophages, DCs, and activated T cells. HLA-DR is a heterodimeric transmembrane protein composed of α and β subunits and plays an important role in the presentation of peptides to CD4+ T lymphocytes.

Details
Host Mouse
Isotype IgG2b, kappa
Reactivity Human
Conjugate PE-Cyanine5
Laser Blue Laser, Green Laser, Yellow-Green Laser
Excite 488 - 561 nm
Legal FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT # 5,268,486, 5,569,587 AND 5,627,027 AND FOREIGN EQUIVALENTS AND PENDING APPLICATIONS. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. sale, lease, license or other transfer of the material or any material derived or produced from it; 2. sale, lease, license or other grant of rights to use this Material or any material derived or produced from it; 3. use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO EBIOSCIENCE, INC. 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA 92121 USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
17-9956 Anti-Human HLA-DR APC 633 - 647 nm 660 nm FC RUO
25-9956 Anti-Human HLA-DR PE-Cyanine7 488 - 561 nm 775 nm FC RUO
13-9956 Anti-Human HLA-DR Biotin FC RUO
48-9956 Anti-Human HLA-DR eFluor® 450 405 nm 450 nm FC RUO
12-9956 Anti-Human HLA-DR PE 488 - 561 nm FC RUO
56-9956 Anti-Human HLA-DR Alexa Fluor® 700 633 - 647 nm 723 nm FC RUO
45-9956 Anti-Human HLA-DR PerCP-Cyanine5.5 488 nm FC RUO
93-9956 Anti-Human HLA-DR eFluor® 605NC 350 - 590 nm 605 nm FC RUO
11-9956 Anti-Human HLA-DR FITC 488 nm FC RUO
47-9956 Anti-Human HLA-DR APC-eFluor® 780 633 - 647 nm 780 nm FC RUO
14-9956 Anti-Human HLA-DR Purified FC, IHC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
15-4732 Mouse IgG2b K Isotype Control PE-Cyanine5 488 - 561 nm FC RUO
References

References: Fullen, D. R. and J. T. Headington. 1998. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas. J Cutan Pathol. 25(10): 553-8.

Hua, Z. X., K. E. Tanaka, et al. 1998. Immunoreactivity for LN2 and LN3 distinguishes small cell carcinomas from non-small cell carcinomas in the lung. Hum Pathol. 29(12): 1441-6.

Ioachim, H. L., S. E. Pambuccian, et al. 1996. Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications. Am J Surg Pathol. 20(1): 64-71.

Davey, F. R., S. Olson, et al. 1988. The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. Am J Surg Pathol. 12(9): 699-707.

Norton, A. J. and P. G. Isaacson. 1987. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am J Pathol. 128(2): 225-40.


View More Products

AntigensArea of BiologyCell TypeFormats